Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Showcases SAW-48 Automated Nucleic Acid Workstation

By LabMedica International staff writers
Posted on 23 May 2023

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is highlighting its comprehensive range of laboratory solutions that are designed to address the diagnostic needs of laboratories at this year's WorldLab-EuroMedLab. As a bronze sponsor of the Congress, Bioperfectus is welcoming visitors at the La Nuvola Convention Center in Rome to its booth, ready to present its full range of diagnostic solutions to enhance the efficiency and quality of healthcare services.

Bioperfectus is showcasing the SAW-48 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. The SAW-48 offers the same basic functions as the SAW-96 but in a smaller and lighter form factor. Also on display at the booth is the SSNP-2000B nucleic acid extraction system, a laboratory medical device that integrates state-of-the-art technologies to enable automatic nucleic acid extraction of up to 32 samples at a time.

In addition, Bioperfectus is highlighting the SSNP-A6 nucleic acid extraction system, an in-vitro diagnostic medical device that leverages cutting-edge mechanical, electronic, and software technologies to facilitate the automated extraction of nucleic acids from samples. Visitors to the Bioperfectus booth will have the opportunity to experience the STC-96A Plus Real-Time PCR system, a highly flexible, efficient, and reliable instrument that marks a breakthrough in real-time PCR analysis of gene expression and genetic variation. The STC-96A allows users to perform two different PCR assays on a single instrument with separate-controlled programs, offering enhanced versatility. BioPerfectus is also presenting its diagnostic solutions for the detection of respiratory and gastrointestinal infections, cervical cancer screening, as well as vector-borne and zoonotic diseases.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.